The BIO CEO & Investor Conference Presenting Company Application Is Open!
The aim of the Annual BIO CEO & Investor Conference is to bring together a select group of established public biotech companies, a select group of late-stage private companies, and investors to foster the development of important new medicines that will expand the industry’s pipeline. With this mission, companies exclusively developing medical devices or providing industry services will not be considered. All final qualifications are determined by BIO.
Returning in 2015! Due to its success over the past several years, BIO CEO & Investor Conference will feature a special track with presentations given by private companies. In 2014, 30 private company presentations were scheduled and sold out to standing room only audiences. Presentations in this track will be 13 minutes in length, and will be reserved specifically for established private companies (past Series B round and >$25M raised to date).
Companies that meet the stated criteria should FULLY complete the application form below. Please note, there are registration and presentation fees associated with presenting. Visit our Registration Page for more information.
Only the Company Description and Therapeutic Area of Focus may be used in conference materials. The rest of the information below is used for selection purposes only and will not be printed in conference handbooks, or as profiles for the partnering system.